Genomics - Global - World Health Organization (WHO)
Genomics is evolving rapidly, and its potential impact for the future of human health cannot yet be known. Human genomics knowledge and technologies provide new ways to prevent and manage many diseases, and opportunities to achieve global public health goals. Genomic knowledge of other organisms contributes to the understanding of human health and diseases, the interconnectedness across ...

Genomics costing tool, user manual, 2nd edition
The first edition of the genomics costing tool (GCT) facilitates budgeting and resource mobilization for infrastructure, workforce, biosafety and quality assurance associated with SARS-CoV-2 genomic surveillance. This tool will be useful to country, regional and global policymakers, health administrators and economists, laboratory directors, quality managers, donor institutions and other ...

Partner spotlight: Centre for Pathogen Genomics celebrates two years of ...
The Centre for Pathogen Genomics is a leading academic and training hub for infectious diseases genomics in the Asia-Pacific region at the University of Melbourne, based at the Doherty Institute. The Centre’s mission is to build collaborative partnerships to support accessible pathogen genomics globally, through translational research and research training; and also to provide support for ...

WHO publishes new global analysis revealing major equity gaps in human ...
Geneva, 2025 – The World Health Organization (WHO) has published a new global analysis of human genomics in clinical research, covering more than three decades of studies registered between 1990 and 2024. The report, Human genomics technologies in clinical studies – the research landscape, together with an accompanying interactive dashboard provides the most comprehensive overview to date ...

WHO establishes communities of practice for pathogen genomics surveillance
Within the pathogen genomics workstream, the group has focused on supporting harmonization and in-country deployment of the bioinformatics analysis of MPXV genome data to strengthen quality of the analysis. Additionally, the group is developing a guidance document outlining analytical considerations for MPXV genomic surveillance.

Indonesia joins regional effort to advance genomics in public health
Human genomics is transforming how diseases are diagnosed and treated, enabling earlier detection, more effective therapies and tailored public health responses. Yet many countries in the Western Pacific still lack the infrastructure, policies and skilled teams needed to make this a reality, and limited resources add to the challenge.

WHO’s Science Council launches report calling for equitable expansion ...
WHO’s Science Council of experts has issued its first report, on accelerating access to genomics for global health.

WHO Science Council report calling for equitable expansion of genomics ...
The first report of the WHO Science Council calling for expanded access and use of genomics is now available in Chinese. The publication, Accelerating access to genomics for global health: promotion, implementation, collaboration, and ethical, legal, and social issues: a report of the WHO Science Council, presents fifteen actions recommended by the WHO Science Council to achieve the goal of ...

WHO global genomic surveillance strategy for pathogens with pandemic ...
The Strategy provides a high-level unifying framework to leverage existing capacities, address barriers and strengthen the use of genomic surveillance in the detection, monitoring and response to public health threats. Genomic surveillance is part of the broader surveillance and laboratory system, and its implementation should reinforce end-to-end capacities including sample collection ...

A milestone in public health and disease surveillance: Fiji launches ...
In a major advancement in public health in the Pacific, Fiji has launched its Pathogen Genomics Laboratory. The state-of-the-art facility, based at the Fiji Centre for Disease Control, marks a historic milestone in the country’s ability to rapidly detect, characterize, and respond to infectious disease threats - from antimicrobial-resistant bacteria to viral diseases like influenza, COVID-19 ...